Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

FDA confirms Class I recall for Johnson & Johnson devices due to durability concerns
The issue, first reported in September, was linked to five patient injuries. Devices not being actively used should be returned to Johnson & Johnson MedTech for updates.
Nuclear cardiology expands beyond perfusion imaging as it enters a new era
Beyond amyloidosis, nuclear cardiology is also increasingly used to image inflammation and infection in the myocardium, especially in diseases such as cardiac sarcoidosis and myocarditis.
How clinicians can combat health disparities in cardio-oncology
Researchers, for example, could improve disparities by performing their tests on more diverse groups of patients. Daniel Addison, MD, shared his perspective with Cardiovascular Business.
Most adults know nothing about CKM syndrome—but it impacts nearly everyone
Nearly 90% of adults are believed to already have at least one risk factor of CKM syndrome. The American Heart Association hopes patient education and physician collaborations can help increase awareness about this dangerous condition.
FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes
Rybelsus from Novo Nordisk is officially the first oral GLP-1 drug approved for this indication. The FDA's decision was based on the SOUL trial, which included data from more than 9,000 patients with type 2 diabetes.

RSNA’s $30M policy did not insure against COVID-19 cancellation, judge rules

The society was seeking coverage for losses related to last year's annual meeting, but a federal judge said the event insurance clearly excluded communicable diseases.

Bayer's big news: Finerenone gains FDA approval for patients with chronic kidney disease, type 2 diabetes

The medication is approved for slowing CKD progression in patients with type 2 diabetes. It can also reduce a patient's risk of heart failure hospitalization and cardiovascular death.

Imaging technique could help predict heart rhythm issues among COVID-19 patients

"This is a safe and affordable new data point that can clue us in about who might develop atrial fibrillation," one researcher said.

Additional experience pays off when performing endovascular treatments

Researchers tracked the outcomes of more than 4,500 procedures performed over five years, sharing their findings in Stroke.

Echocardiogram add-on predicts patients at risk of developing heart problems from COVID-19

Speckle-tracking strain is a safe, affordable way to gain clues into who may develop atrial fibrillation and require additional monitoring down the road.

A fresh look at why high-fat diets can lead to atherosclerosis

Researchers in Japan are focused on uncovering new data on the body's response to a high-fat diet, hoping their work can lead to improved treatment options in the future.

Embrace plant-based foods, limit most meats to avoid heart disease

The expert analysis includes insights taken from observational studies and large clinical trials.

Undergoing TAVR and mitral valve interventions during a single hospital visit may put patients at risk

The risk of in-hospital mortality, for instance, increased considerably when patients underwent TAVR and a mitral procedure.

Clinical

FDA confirms Class I recall for Johnson & Johnson devices due to durability concerns

Nuclear cardiology expands beyond perfusion imaging as it enters a new era

How clinicians can combat health disparities in cardio-oncology

Most adults know nothing about CKM syndrome—but it impacts nearly everyone

FDA approves oral semaglutide for reducing cardiovascular risks in adults with type 2 diabetes